1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Reporter Account

StemCells21 develops integrated protocol for Down syndrome

Using umbilical cord blood-derived stem cells in combination with dietary supplements may enhance brain tissue development in patients with Down syndrome.

FOR IMMEDIATE RELEASE

 
Attachment
Attachment
PRLog (Press Release) - Aug 26, 2009 -
StemCells21 and its partner Integrated Medical Center have released details of a treatment plan to help those with Down syndrome. It combines Mesenchymal and CD34 stem cells derived from umbilical cord blood with growth factors, neurotropic supplements, stem cell nutrition and antioxidant supplements.

The combination offers the potential to increase brain tissue development and halt the production of the abnormal protein which interferes with such development. The safe, outpatient treatment is available in Bangkok and takes seven days.

Down syndrome (DS), also called Trisomy 21, is a condition in which extra genetic material causes delays in the way a child develops, both mentally and physically. It affects about 1 in every 800 babies.
The physical features and medical problems associated with Down syndrome can vary widely from child to child. While some with DS need a lot of medical attention, others lead healthy lives.
Though Down syndrome can't be prevented, it can be detected before a child is born. The health problems that can go along with DS can be treated, and there are many resources within communities to help children and their families who are living with the condition.

StemCells21
Stem Cells 21 http://www.StemCells21.com is the adult stem cell treatment division of Jai Communications Ltd., an expat company based in Bangkok. In partnership with clinics and hospitals they manage patient care for foreigners going to Thailand for medical care. Their partner laboratories and physicians have developed a range of treatment protocols using either umbilical cord blood-derived stem cells or adipose-derived cells, from the patient’s own body, for a wide variety of progressive and debilitating diseases.

Photo:
http://www.prlog.org/10321772/1

# # #

Jai Communications Limited is a Hong Kong registered cellular medicine management company. They specialize in taking care of patients in Bangkok and also provide a range of tailor-made adult stem cell therapies for a wide variety of diseases.

--- end ---

Click to Share

Contact Email:
***@stemcells21.com Email Verified
Source:Jai Communications Ltd
Phone:+6681987819
Zip:10900
State/Province:Bangkok
Country:Thailand
Industry:Biotech, Health, Medical
Tags:, , , , , cd34, ,
Last Updated:Aug 26, 2009
Shortcut:http://prlog.org/10321772
Disclaimer:   Issuers of the press releases are solely responsible for the content of their press releases. PRLog can't be held liable for the content posted by others.   Report Abuse

Latest Press Releases By “

More...

Upcoming Press Releases...



  1. SiteMap
  2. Privacy Policy
  3. Terms of Service
  4. Copyright Notice
  5. About
  6. Advertise
Like PRLog?
3.5K1.4K1.3K
Click to Share